Vimarsana
Biggest News Aggregation in the World

Page 7 - Priya Singhal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Priya Singhal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Priya Singhal Today - Breaking & Trending Today

Biogen (NASDAQ:BIIB) Releases Quarterly Earnings Results, Beats Expectations By $0.22 EPS - Vimarsana News

Biogen (NASDAQ:BIIB) Releases Quarterly Earnings Results, Beats Expectations By $0.22 EPS

Biogen (NASDAQ:BIIB – Get Free Report) issued its quarterly earnings results on Wednesday. The biotechnology company reported $3.67 earnings per share for the quarter, topping analysts’ consensus estimates of $3.45 by $0.22, Briefing.com reports. Biogen had a return on equity of 14.83% and a net margin of 12.07%. The firm had revenue of $2.29 billion […]

Biogen (NASDAQ:BIIB) Releases FY 2024 Earnings Guidance - Vimarsana News

Biogen (NASDAQ:BIIB) Releases FY 2024 Earnings Guidance

Biogen (NASDAQ:BIIB – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 15.000-16.000 for the period, compared to the consensus estimate of 15.460. The company issued revenue guidance of -. Biogen also updated its FY24 guidance to $15.00-16.00 EPS. Wall […]

Source: wkrb13.com
Biogen: Don't expect any big acquisitions this year - Vimarsana News

Biogen: Don't expect any big acquisitions this year

BioPharma

Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript - Vimarsana News

Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript

Biogen Inc. misses on earnings expectations. Reported EPS is $3.3 EPS, expectations were $3.45.

Biogen (NASDAQ:BIIB) Announces Quarterly Earnings Results, Beats Estimates By $0.22 EPS - Vimarsana News

Biogen (NASDAQ:BIIB) Announces Quarterly Earnings Results, Beats Estimates By $0.22 EPS

Biogen (NASDAQ:BIIB – Get Free Report) posted its earnings results on Wednesday. The biotechnology company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $3.45 by $0.22, Briefing.com reports. The company had revenue of $2.29 billion during the quarter, compared to analysts’ expectations of $2.31 billion. Biogen had a net margin […]

Source: wkrb13.com